To evaluate the effect of Metamin 3D on improvement of glucose and lipid on Taiwanese subjects with metabolic syndrome.
The Metamin 3D consists of mixed extractives of nature plants, including soy bean protein, bitter melon, red yeast rice, green algae and trisodium glycyrrhizinate. the improvement of lipid and glucose was reported respectively previously. We design a prospective, double-blinded and placebo-controlled study to evaluate the improvement on metabolic syndrome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
110
Metamin 3D is composed by red yeast rice, bitter gourd, chlorella, soy peptide and licorice extract is a commercial product designed by Uni-President enterprises corp in Taiwan
Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital
Taichang, Taiwan
Total cholesterol
To assess the change of total cholesterol between 0 and 12 weeks
Time frame: 12 weeks
Total cholesterol
To assess the change of lipid profiles during study
Time frame: 4 and 8 weeks
Triglycerides
To assess the change of lipid profiles during study
Time frame: 4 and 8 weeks
Low-density lipoprotein cholesterol
LDL cholesterol: To assess the lipid profiles during study
Time frame: 4, 8 and 12 weeks
The plasma insulin by meal tolerant test
Time frame: 4 and 8 weeks
Glycosylated hemoglobin
HbA1c: To assess the glycemic control during the study period
Time frame: 4 and 8 weeks
Fasting plasma glucose
withdrawal if fasting glucose greater than 250 mg/dl
Time frame: 4 and 8 weeks
Systolic and diastolic blood pressure
Time frame: 4, 8 and 12 weeks
Triglycerides
To assess the change of lipid profiles between 0 and 12 weeks
Time frame: 12 weeks
The plasma glucose by meal tolerant test
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 weeks
Glycosylated hemoglobin
To assess the change of HbA1c between 0 and 12 weeks
Time frame: 12 weeks
Fasting plasma glucose
withdrawal if fasting glucose greater than 250 mg/dl
Time frame: 12 weeks
Aspartate aminotransferase
GOT: To assess the liver functions at 0 and 12 weeks
Time frame: 12 weeks
Alanine aminotransferase
GPT: To assess the liver functions at 0 and 12 weeks
Time frame: 12 weeks
Creatinine
Serum creatinine: To assess the renal function at 0 and 12 weeks
Time frame: 12 weeks